Carregant...

Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells

Prevention of the initial infection of mucosal dendritic cells (DC) and interruption of the subsequent transmission of HIV-1 from DC to T cells are likely to be important attributes of an effective human immunodeficiency virus type 1 (HIV-1) vaccine. While anti-HIV-1 neutralizing antibodies have bee...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Frankel, Sarah S., Steinman, Ralph M., Michael, Nelson L., Kim, Silvia Ratto, Bhardwaj, Nina, Pope, Melissa, Louder, Mark K., Ehrenberg, Philip K., Parren, Paul W. H. I., Burton, Dennis R., Katinger, Hermann, VanCott, Thomas C., Robb, Merlin L., Birx, Deborah L., Mascola, John R.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 1998
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC110490/
https://ncbi.nlm.nih.gov/pubmed/9811714
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!